---
figid: PMC7947364__fonc-11-628359-g001
figlink: pmc/articles/PMC7947364/figure/f1/
number: Figure 1
caption: Summary of the cellular metabolic effects of hyperglycemia in cancer. GLUT1,
  Glucose transporter 1; PPP, Pentose phosphate pathway; EGFR, Epidermal growth factor
  receptor; IF, Inflammatory factors; TF, Transcription factors; HIF, Hypoxia-inducible
  factor-1; HK2, Hexokinase2; PKM1, Pyruvate kinase M1; EMT, Epithelial-mesenchymal
  transition; FASN/FAS, Fatty acid synthase; ER, Estrogen receptor; IGF, Insulin growth
  factor; PI3K, Intracellular phosphatidylinositol kinase; AKT, Protein kinase B;
  mTOR, Mammalian target of rapamycin; Grb2, Growth factor receptor-bound protein2;
  MAPK, Mitogen-activated protein kinase.
pmcid: PMC7947364
papertitle: 'Hyperglycemia and Chemoresistance in Breast Cancer: From Cellular Mechanisms
  to Treatment Response.'
reftext: Jie Qiu, et al. Front Oncol. 2021;11:628359.
pmc_ranked_result_index: '5071'
pathway_score: 0.9710912
filename: fonc-11-628359-g001.jpg
figtitle: Summary of the cellular metabolic effects of hyperglycemia in cancer
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7947364__fonc-11-628359-g001.html
  '@type': Dataset
  description: Summary of the cellular metabolic effects of hyperglycemia in cancer.
    GLUT1, Glucose transporter 1; PPP, Pentose phosphate pathway; EGFR, Epidermal
    growth factor receptor; IF, Inflammatory factors; TF, Transcription factors; HIF,
    Hypoxia-inducible factor-1; HK2, Hexokinase2; PKM1, Pyruvate kinase M1; EMT, Epithelial-mesenchymal
    transition; FASN/FAS, Fatty acid synthase; ER, Estrogen receptor; IGF, Insulin
    growth factor; PI3K, Intracellular phosphatidylinositol kinase; AKT, Protein kinase
    B; mTOR, Mammalian target of rapamycin; Grb2, Growth factor receptor-bound protein2;
    MAPK, Mitogen-activated protein kinase.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - USP6NL
  - EGFR
  - IGF1R
  - CDH1
  - SETD2
  - AKT2
  - AKT3
  - AKT1
  - HK2
  - FASN
  - GRB2
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - HRAS
  - KRAS
  - NRAS
  - MAPK14
  - MAPK3
  - MAPK8
  - MAPK11
  - MAPK13
  - MAPK12
  - MAPK1
  - MAPK9
  - MAPK10
  - MAK
  - Lactic acid
  - Pyruvate
  - TCA
  - ATP
  - Hyperglucemia
genes:
- word: USP6NL
  symbol: USP6NL
  source: hgnc_symbol
  hgnc_symbol: USP6NL
  entrez: '9712'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
- word: IGF-1R,
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: e-cadherin,
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: HIF-1
  symbol: HIF-1
  source: hgnc_alias_symbol
  hgnc_symbol: SETD2
  entrez: '29072'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: HK2
  symbol: HK2
  source: hgnc_symbol
  hgnc_symbol: HK2
  entrez: '3099'
- word: FASN
  symbol: FASN
  source: hgnc_symbol
  hgnc_symbol: FASN
  entrez: '2194'
- word: Grb2
  symbol: GRB2
  source: hgnc_symbol
  hgnc_symbol: GRB2
  entrez: '2885'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: МАРК
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: МАРК
  symbol: MAK
  source: hgnc_symbol
  hgnc_symbol: MAK
  entrez: '4117'
chemicals:
- word: Lactic acid
  source: MESH
  identifier: D019344
- word: Pyruvate
  source: MESH
  identifier: D011773
- word: TCA
  source: MESH
  identifier: C000589078
- word: ATP
  source: MESH
  identifier: D000255
diseases:
- word: Hyperglucemia
  source: ''
  identifier: ''
---
